Forest VI - Search Results

1

Molecular Mutations and Clinical Behavior in Bethesda III and IV Thyroid Nodules: A Comparative Study.

Payne AE, Lefebvre C, Minello M, Rajab M, da Silva SD, Pusztaszeri M, Hier MP, Forest VI. Payne AE, et al. Among authors: forest vi. Cancers (Basel). 2024 Dec 20;16(24):4249. doi: 10.3390/cancers16244249. Cancers (Basel). 2024. PMID: 39766147 Free PMC article.

2

Are Bethesda III Thyroid Nodules More Aggressive than Bethesda IV Thyroid Nodules When Found to Be Malignant?

Turkdogan S, Pusztaszeri M, Forest VI, Hier MP, Payne RJ. Turkdogan S, et al. Among authors: forest vi. Cancers (Basel). 2020 Sep 9;12(9):2563. doi: 10.3390/cancers12092563. Cancers (Basel). 2020. PMID: 32916807 Free PMC article.

3

Molecular Testing for Thyroid Nodules: The Experience at McGill University Teaching Hospitals in Canada.

Rajab M, Payne RJ, Forest VI, Pusztaszeri M. Rajab M, et al. Among authors: forest vi. Cancers (Basel). 2022 Aug 26;14(17):4140. doi: 10.3390/cancers14174140. Cancers (Basel). 2022. PMID: 36077677 Free PMC article. Review.

4

Prognostic Indicators of EIF1AX-Mutated Thyroid Tumor Malignancy and Cancer Aggressiveness.

Bandargal S, Chen T, Pusztaszeri MP, Forest VI, da Silva SD, Payne RJ. Bandargal S, et al. Among authors: forest vi. Cancers (Basel). 2022 Dec 11;14(24):6097. doi: 10.3390/cancers14246097. Cancers (Basel). 2022. PMID: 36551583 Free PMC article.

5

Coexisting Molecular Alterations Increase the Risk of Malignancy in Thyroid Nodules with Copy Number Alterations.

Rajab M, Bandargal S, Pusztaszeri MP, Forest VI, Alohali S, Silva SDD, Tamilia M, Payne RJ. Rajab M, et al. Among authors: forest vi. Cancers (Basel). 2022 Dec 13;14(24):6149. doi: 10.3390/cancers14246149. Cancers (Basel). 2022. PMID: 36551633 Free PMC article.

6

Surgical Outcomes of Thyroid Nodules Positive for Gene Expression Alterations Using ThyroSeq V3 Genomic Classifier.

Salameh S, Rajab M, Forest VI, Pusztaszeri M, Payne RJ. Salameh S, et al. Among authors: forest vi. Cancers (Basel). 2022 Dec 22;15(1):49. doi: 10.3390/cancers15010049. Cancers (Basel). 2022. PMID: 36612045 Free PMC article.

7

Effect of Having Concurrent Mutations on the Degree of Aggressiveness in Patients with Thyroid Cancer Positive for TERT Promoter Mutations.

Alohali S, Payne AE, Pusztaszeri M, Rajab M, Forest VI, Hier MP, Tamilia M, Payne RJ. Alohali S, et al. Among authors: forest vi. Cancers (Basel). 2023 Jan 8;15(2):413. doi: 10.3390/cancers15020413. Cancers (Basel). 2023. PMID: 36672362 Free PMC article.

8

Characteristics of PTEN Mutation in Thyroid Tumours: A Retrospective Chart Review.

Bandargal S, Rajab M, Forest VI, Pusztaszeri MP, Hier MP, da Silva SD, Payne RJ. Bandargal S, et al. Among authors: forest vi. Cancers (Basel). 2023 Mar 3;15(5):1575. doi: 10.3390/cancers15051575. Cancers (Basel). 2023. PMID: 36900366 Free PMC article.

9

The Difference in Clinical Behavior of Gene Fusions Involving RET/PTC Fusions and THADA/IGF2BP3 Fusions in Thyroid Nodules.

Tali G, Payne AE, Hudson TJ, da Silva SD, Pusztaszeri M, Tamilia M, Forest VI. Tali G, et al. Among authors: forest vi. Cancers (Basel). 2023 Jun 28;15(13):3394. doi: 10.3390/cancers15133394. Cancers (Basel). 2023. PMID: 37444504 Free PMC article.

10

The Impact of BRAF V600E Mutation Allele Frequency on the Histopathological Characteristics of Thyroid Cancer.

Abdulhaleem M, Bandargal S, Pusztaszeri MP, Rajab M, Greenspoon H, Krasner JR, Da Silva SD, Forest VI, Payne RJ. Abdulhaleem M, et al. Among authors: forest vi. Cancers (Basel). 2023 Dec 25;16(1):113. doi: 10.3390/cancers16010113. Cancers (Basel). 2023. PMID: 38201541 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

67 results

Search Page

Filters